Table 2.

Relation Between Hormone Replacement Therapy Use and Perceived Risk, Quality of Life, and Selected Clinical Characteristics.

CharacteristicRO*95% CIROadj95% CI
Race, white vs nonwhite1.60.7, 3.91.20.3, 4.7
Smoking status, ever vs never1.91.1, 3.31.20.5, 2.9
Exercise, 3/wk0.60.4, 1.00.60.3, 1.4
Fractures, any history0.40.1, 0.90.50.1, 2.0
Symptoms of menopause, any2.61.6, 4.56.32.3, 17.6
Bone density treatment, any0.50.3, 1.00.70.2, 2.1
Herbal medicine, any1.60.9, 2.91.90.8, 5.0
  Perceived risk difference
High- vs low-risk difference§
 Osteoporosis3.42.0, 5.94.72.1, 10.5
 Myocardial infarction3.31.9, 6.02.51.2, 5.3
 Uterine cancer0.50.3, 0.91.20.5, 2.8
 Breast cancer0.50.3, 0.90.50.2, 1.1
Quality-of-life difference
High vs low QOL difference
 Osteoporosis2.01.2, 3.42.41.0, 6.0
 Myocardial infarction1.40.9, 2.31.70.7, 3.9
 Uterine cancer1.40.7, 2.61.70.5, 5.8
 Breast cancer2.81.6, 5.03.61.2, 10.7
  • * RO = relative odds, the odds of an HRT user having a characteristic divided by odds of an HRT nonuser having a characteristic.

  • 95 percent confidence intervals.

  • Relative odds adjusted by multivariate logistic regression, also including age (years).

  • § Perceived risk difference = (lifetime probability on HRT) − (lifetime probability off HRT); the mean is used as the cutoff for the high and low group, except breast cancer for which the median is used.

  • Quality of life (QOL) difference = QOL (current state of health) − QOL (with disease); the mean is used as the cutoff for the high and low group.